JPS595588B2 - シンキナブチロフエノンユウドウタイ オヨビ ソノエン ノ セイホウ - Google Patents

シンキナブチロフエノンユウドウタイ オヨビ ソノエン ノ セイホウ

Info

Publication number
JPS595588B2
JPS595588B2 JP47058789A JP5878972A JPS595588B2 JP S595588 B2 JPS595588 B2 JP S595588B2 JP 47058789 A JP47058789 A JP 47058789A JP 5878972 A JP5878972 A JP 5878972A JP S595588 B2 JPS595588 B2 JP S595588B2
Authority
JP
Japan
Prior art keywords
acid
formula
yudoutai
synkinabutylofenon
sonoen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP47058789A
Other languages
English (en)
Japanese (ja)
Other versions
JPS4914477A (fr
Inventor
紀久雄 笹島
勝 中尾
勇 丸山
圭一 小野
重成 片山
茂穂 稲葉
久夫 山本
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sumitomo Chemical Co Ltd
Original Assignee
Sumitomo Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sumitomo Chemical Co Ltd filed Critical Sumitomo Chemical Co Ltd
Priority to JP47058789A priority Critical patent/JPS595588B2/ja
Priority to SE7307963A priority patent/SE397089B/xx
Priority to CH826373A priority patent/CH592624A5/xx
Priority to FR7320929A priority patent/FR2187346B1/fr
Priority to NL7308000A priority patent/NL7308000A/xx
Priority to GB2762773A priority patent/GB1414020A/en
Priority to CA173,679A priority patent/CA1023362A/fr
Priority to BE132163A priority patent/BE800791A/fr
Priority to DE2329813A priority patent/DE2329813A1/de
Priority to HUSU819A priority patent/HU167380B/hu
Publication of JPS4914477A publication Critical patent/JPS4914477A/ja
Priority to US05/617,730 priority patent/US4009173A/en
Publication of JPS595588B2 publication Critical patent/JPS595588B2/ja
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D211/62—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
    • C07D211/64—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4 having an aryl radical as the second substituent in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/34—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
JP47058789A 1972-06-12 1972-06-12 シンキナブチロフエノンユウドウタイ オヨビ ソノエン ノ セイホウ Expired JPS595588B2 (ja)

Priority Applications (11)

Application Number Priority Date Filing Date Title
JP47058789A JPS595588B2 (ja) 1972-06-12 1972-06-12 シンキナブチロフエノンユウドウタイ オヨビ ソノエン ノ セイホウ
SE7307963A SE397089B (sv) 1972-06-12 1973-06-06 Forfarande for framstellning av butyrofenonderivat
CH826373A CH592624A5 (fr) 1972-06-12 1973-06-07
FR7320929A FR2187346B1 (fr) 1972-06-12 1973-06-08
NL7308000A NL7308000A (fr) 1972-06-12 1973-06-08
GB2762773A GB1414020A (en) 1972-06-12 1973-06-11 Butyrophenone derivatives and production thereof
CA173,679A CA1023362A (fr) 1972-06-12 1973-06-11 Derives du butyrophenone et leur fabrication
BE132163A BE800791A (fr) 1972-06-12 1973-06-12 Derives de butyrophenone et leur production
DE2329813A DE2329813A1 (de) 1972-06-12 1973-06-12 Butyrophenonderivate, ihre salze, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
HUSU819A HU167380B (fr) 1972-06-12 1973-06-12
US05/617,730 US4009173A (en) 1972-06-12 1975-09-29 Butyrophenone derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP47058789A JPS595588B2 (ja) 1972-06-12 1972-06-12 シンキナブチロフエノンユウドウタイ オヨビ ソノエン ノ セイホウ

Publications (2)

Publication Number Publication Date
JPS4914477A JPS4914477A (fr) 1974-02-07
JPS595588B2 true JPS595588B2 (ja) 1984-02-06

Family

ID=13094324

Family Applications (1)

Application Number Title Priority Date Filing Date
JP47058789A Expired JPS595588B2 (ja) 1972-06-12 1972-06-12 シンキナブチロフエノンユウドウタイ オヨビ ソノエン ノ セイホウ

Country Status (10)

Country Link
JP (1) JPS595588B2 (fr)
BE (1) BE800791A (fr)
CA (1) CA1023362A (fr)
CH (1) CH592624A5 (fr)
DE (1) DE2329813A1 (fr)
FR (1) FR2187346B1 (fr)
GB (1) GB1414020A (fr)
HU (1) HU167380B (fr)
NL (1) NL7308000A (fr)
SE (1) SE397089B (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025157901A1 (fr) * 2024-01-26 2025-07-31 Aneurotech Bv Promédicaments d'acides gras de pipéridine carboxamide

Also Published As

Publication number Publication date
CA1023362A (fr) 1977-12-27
HU167380B (fr) 1975-09-27
NL7308000A (fr) 1973-12-14
FR2187346A1 (fr) 1974-01-18
JPS4914477A (fr) 1974-02-07
BE800791A (fr) 1973-12-12
FR2187346B1 (fr) 1976-12-31
GB1414020A (en) 1975-11-12
CH592624A5 (fr) 1977-10-31
SE397089B (sv) 1977-10-17
DE2329813A1 (de) 1974-01-03

Similar Documents

Publication Publication Date Title
JPS62294674A (ja) １，４−二置換ピペラジン誘導体、これを含む薬用組成物並びにその製造方法
US2872453A (en) Indole derivatives
JP2521157B2 (ja) 四環式抗うつ剤
JPH0585553B2 (fr)
JPS6110584A (ja) イミダゾイソキノリン化合物およびその製造方法
US3491097A (en) 3-(piperazinoalkyl)-pyrazoles
JPH04230382A (ja) クエン酸ノベラスチン及びその製法
DE3410168A1 (de) Neue isochinolin-dione, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel sowie zwischenprodukte
JPS6112912B2 (fr)
Cavallini et al. New Anti-viral Compounds with Considerable Activity in vivo--I. Biphenyl Derivatives
US4052404A (en) Indolo (2,3-α)quinolizines
US2655510A (en) Water-soluble mono-betaine hydrazones of the aminochromes and process of preparing same
Rao et al. Streponigrin and related compounds. II. Synthesis of the c‐ring precursors
US2726244A (en) Water-soluble mono-betaine hydrazones of the aminochromes and process of preparing same
JPH02268162A (ja) ジフェニルピリジン誘導体
US2785170A (en) 2-[benzyl (2-dimethylaminoethyl) amino]-pyridine nu-oxides
JPH06511487A (ja) ベンゾ［ｂ］ナフチリジン類の製造方法
US2359260A (en) Synthesis of vitamin b6
JPH0517448A (ja) １４−Ｏ−ｐ−クロロベンゾイルアコニンおよび鎮痛・抗炎症剤
US3144457A (en) Nu-(2-phthalimidoethyl) quaternary ammonium salts of triethylenediamine
JPS605599B2 (ja) アミノベンゾフエノン誘導体の製造法
US3048586A (en) Novel derivatives of phenoxazine and processes for their preparation
US3520885A (en) Phenothiazine salts
US3499890A (en) Certain octahydro-1,12-trimethyleneindolo(2,3-a)quinolizines
US2489351A (en) Preparation of benzotriazine compounds